The European digital doctor that raised $500M to conquer six countries — then closed five when the pandemic-era demand disappeared and every consultation still lost money
Cascading layoffs that accelerated the decline · Fatal mistake: Direct-to-consumer telehealth unit economics could not cover physician costs at any subscription price point — structural loss per consultation regardless of scale
Evaluating only Kry (Livi)’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Overexpansion.
Key Events Timeline
FUNDING
SoftBank Vision Fund 2 leads $300M Series D; Kry valued at ~$2B; Johannes Schildt named to Forbes Europe 30 Under 30; described as European leader in digital primary care.
LAYOFF
Kry closes German operations citing market conditions; first major market exit signals the multi-country expansion strategy is unsustainable.
LAYOFF
Kry announces 90-employee reduction in Sweden; consolidates to Sweden, France (Livi), and UK. Headcount falls below 500 from peak 2,000.
SHUTDOWN
Kry closes Norwegian operations; further staff reductions bring total headcount below 200 from peak 2,000; original pan-European vision abandoned.
ACQUISITION ATTEMPT
Kry sells UK Livi brand to French competitor Doctolib for undisclosed sum; effectively exits English-speaking market; remaining operations limited to Sweden and France.
Full Analysis
Free · no account needed
Documented cause
Kry launched in Sweden in 2015 as a smartphone app connecting patients with licensed physicians within minutes, addressing long wait times in Scandinavian national health systems. Early growth was strong, and the model expanded into France (under the Livi brand), the United Kingdom, Germany, Norway, and Spain, raising over $500 million including a $300 million Series D in 2021 led by SoftBank Vision Fund 2 at an approximate $2 billion valuation. The pandemic-era digital health surge inflated user numbers and investor appetite simultaneously, masking the fundamental problem: the economics of paying licensed physicians for consultations while charging consumer subscription prices never reached break-even, regardless of volume. Each direct-to-consumer consultation generated more in physician cost than it recovered in subscription revenue. Operational complexity across six regulatory regimes — each with different clinical licensing rules, reimbursement frameworks, and data protection requirements — compounded the burn rate. As pandemic tailwinds faded in 2022, Kry closed operations in Germany and Norway, conducted layoffs that reduced headcount by approximately 90% from its 2,000-employee peak, and sold its UK Livi operations to French competitor Doctolib in 2024 for an undisclosed amount. What remained was a reduced Swedish and French operation with no path to recapturing the vision of becoming Europe's leading digital primary care platform. The $2 billion valuation became a cautionary tale about healthcare unit economics at consumer scale.
Lesson
“Telehealth at scale requires either employer or insurer partnerships (B2B) or government reimbursement (NHS or national health) to work economically. Pure D2C digital healthcare at consumer subscription price points was never going to be profitable without a fundamentally different unit structure. Expanding geography before validating even one market is how a $2B valuation becomes a distressed asset sale.”
Failure anatomy
Collapse type
Mass Layoff Spiral
📉 MEDIUM
Hype cycle
digital health pandemic surge
Moat type
Brand / Clinician Network
Fatal mistake
Direct-to-consumer telehealth unit economics could not cover physician costs at any subscription price point — structural loss per consultation regardless of scale